摘要
目的:进一步探讨白三烯受体拮抗剂在缓解期老年支气管哮喘治疗中的临床实际效果。方法:选择68例老年支气管哮喘患者为研究对象,针对患者治疗效果进行比较分析。结果:两组患者治疗后,FEV1(一秒用力呼气容积)组间比较,治疗组优于对照组,差异具有统计学意义(P<0.05);两组患者治疗后,症状积分组间比较,治疗组优于对照组,差异具有统计学意义(P<0.05)。结论:在缓解期老年支气管哮喘治疗的过程中,应用白三烯受体拮抗剂可以取得显著的临床治疗效果,是临床治疗老年支气管哮喘的可靠选择。
Objective To further explore the clinical efficacy for leukotriene receptor antagonist in the treatment of bronchial asthma in remission older. Method 68 cases of elderly hospitalized patients with bronchial asthma in our hospital from August 2009 to May 2012 were chosen as the research object. The treatment effect of the patients was taken for a comparative analysis. Results After treatment for the two groups, comparison between FEV, groups,the treatment group was better than the control group, P 〈 0. 05 ,the difference was statistically significant. After treatment,the symptom scores were compared between the two groups, the treatment group was better than the control group, and P 〈 0. 05, the difference was statistically significant. Conclusion In the process of remission senile bronchial asthma treatment, leukotriene receptor antagonists can obtain a significant clinical effect, and it is a reliable choice for clinical treatment of senile bronchial asthma.
出处
《吉林医学》
CAS
2013年第25期5100-5101,共2页
Jilin Medical Journal
关键词
白三烯受体拮抗剂
老年支气管哮喘
临床疗效
Leukotriene receptor antagonist
Senile bronchial asthma
Clinical efficacy
